PAVmed subsidiary Veris Health raises $2.5M in equity and warrant offering

PAVmed Inc.

Veris sold 1,785,714 common shares and warrants at $1.40 per share unit.
Gross proceeds of ~$2.5M for development of implantable physiological monitor and working capital.
After offering, PAVmed owns 75.3% of Veris on a fully-diluted basis.
Warrants exercisable after 6 months at $1.40, expire 5 years from exercise or 60 days post-FDA approval.
Investors granted anti-dilution protection and 100% participation rights in future equity raises.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.